Long COVID Research Moonshot Act: A Turning Point for Chronic Illness
The Long COVID Research Moonshot Act (S. 4964), introduced in August 2024, proposes a $1 billion annual investment through 2034 to address the long-term effects of COVID-19 and other infection-associated chronic conditions. The legislation aims to accelerate research, improve patient care, and lay the groundwork for a broader understanding of how infections can contribute to chronic disease.
The bill directs the NIH to establish a Long COVID Research Program, a centralized initiative to investigate causes, risk factors, and treatment strategies. The program would support scientific studies, clinical trials, and public health efforts, with a strong emphasis on collaboration across agencies, transparency, and input from patient communities.
Key features of the bill include:
- Fast-tracked research funding for therapies, diagnostics, and data collection, including for children and underserved populations.
- Comparative studies examining the overlap between Long COVID and conditions such as ME/CFS, postural orthostatic tachycardia syndrome (POTS), and chronic Lyme disease.
- Public data sharing through a registry of clinical trials and a centralized research clearinghouse.
- Pricing protections to ensure federally funded treatments are affordable to the public.
- Public health infrastructure, including grants to state and local health departments for education, training, and care coordination.
- Dedicated Long COVID clinics to deliver integrated, multidisciplinary care nationwide.
The bill recognizes that post-viral illness is not unique to COVID-19. Increasing evidence links infection to a wide range of chronic conditions, including autoimmune diseases, neurodegenerative disorders, and cardiovascular issues.